These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

926 related articles for article (PubMed ID: 32437308)

  • 1. Basic Mechanisms of Diabetic Heart Disease.
    Ritchie RH; Abel ED
    Circ Res; 2020 May; 126(11):1501-1525. PubMed ID: 32437308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.
    Frati G; Schirone L; Chimenti I; Yee D; Biondi-Zoccai G; Volpe M; Sciarretta S
    Cardiovasc Res; 2017 Mar; 113(4):378-388. PubMed ID: 28395009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy targeting cardiac phosphoinositide 3-kinase (p110α) attenuates cardiac remodeling in type 2 diabetes.
    Prakoso D; De Blasio MJ; Tate M; Kiriazis H; Donner DG; Qian H; Nash D; Deo M; Weeks KL; Parry LJ; Gregorevic P; McMullen JR; Ritchie RH
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H840-H852. PubMed ID: 32142359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid metabolism and its implications for type 1 diabetes-associated cardiomyopathy.
    Ritchie RH; Zerenturk EJ; Prakoso D; Calkin AC
    J Mol Endocrinol; 2017 May; 58(4):R225-R240. PubMed ID: 28373293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.
    Jia G; Hill MA; Sowers JR
    Circ Res; 2018 Feb; 122(4):624-638. PubMed ID: 29449364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics.
    Jakubik D; Fitas A; Eyileten C; Jarosz-Popek J; Nowak A; Czajka P; Wicik Z; Sourij H; Siller-Matula JM; De Rosa S; Postula M
    Cardiovasc Diabetol; 2021 Feb; 20(1):55. PubMed ID: 33639953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy.
    Westermeier F; Navarro-Marquez M; López-Crisosto C; Bravo-Sagua R; Quiroga C; Bustamante M; Verdejo HE; Zalaquett R; Ibacache M; Parra V; Castro PF; Rothermel BA; Hill JA; Lavandero S
    Biochim Biophys Acta; 2015 May; 1853(5):1113-8. PubMed ID: 25686534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are targeted therapies for diabetic cardiomyopathy on the horizon?
    Tate M; Grieve DJ; Ritchie RH
    Clin Sci (Lond); 2017 May; 131(10):897-915. PubMed ID: 28473471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondria in diabetic heart failure: from pathogenesis to therapeutic promise.
    Schilling JD
    Antioxid Redox Signal; 2015 Jun; 22(17):1515-26. PubMed ID: 25761843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetic cardiomyopathy: pathophysiological mechanisms of structural and functional changes.].
    Slavíková J; Mistrová E; Dvoráková Chottová M
    Cesk Fysiol; 2016 Oct; 65(2):75-83. PubMed ID: 29489085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of cardiac pathology in diabetes - Experimental insights.
    Varma U; Koutsifeli P; Benson VL; Mellor KM; Delbridge LMD
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1949-1959. PubMed ID: 29109032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis.
    Rajesh M; Mukhopadhyay P; Bátkai S; Arif M; Varga ZV; Mátyás C; Paloczi J; Lehocki A; Haskó G; Pacher P
    Geroscience; 2022 Jun; 44(3):1727-1741. PubMed ID: 35460032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic cardiomyopathy: where we are and where we are going.
    Lee WS; Kim J
    Korean J Intern Med; 2017 May; 32(3):404-421. PubMed ID: 28415836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
    Ansari M; Gopalakrishnan S; Kurian GA
    J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Cardiovascular Disease Induced by Oxidative Stress.
    Kayama Y; Raaz U; Jagger A; Adam M; Schellinger IN; Sakamoto M; Suzuki H; Toyama K; Spin JM; Tsao PS
    Int J Mol Sci; 2015 Oct; 16(10):25234-63. PubMed ID: 26512646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-ischemic diabetic cardiomyopathy may initially exhibit a transient subclinical phase of hyperdynamic myocardial performance.
    Hensel KO
    Med Hypotheses; 2016 Sep; 94():7-10. PubMed ID: 27515189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and Treatment of Diabetic Cardiomyopathy and Heart Failure in Patients with Diabetes Mellitus.
    Nakamura K; Miyoshi T; Yoshida M; Akagi S; Saito Y; Ejiri K; Matsuo N; Ichikawa K; Iwasaki K; Naito T; Namba Y; Yoshida M; Sugiyama H; Ito H
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbreak my heart: targeting mitochondrial autophagy in diabetic cardiomyopathy.
    Kubli DA; Gustafsson ÅB
    Antioxid Redox Signal; 2015 Jun; 22(17):1527-44. PubMed ID: 25808102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction in diabetic cardiomyopathy.
    Duncan JG
    Biochim Biophys Acta; 2011 Jul; 1813(7):1351-9. PubMed ID: 21256163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.